Management of obesity in primary health care;Manejo de la obesidad en Atención Primaria

MEDIFAM - Revista de Medicina Familiar y Comunitaria

Volumn 11, Issue 1, 2001, Pages 4-10

  Mate del Tio M ^a   Cano, M D ^a   Alvarez Sala Walther R ^a   Bilbao Garay, J ^a  

^a NONE   (Spain)

Author keywords

Complications; Obesity; Prevention; Treatment

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HYPERTENSION; METABOLIC DISORDER; OBESITY; OSTEOARTHRITIS; PRIMARY HEALTH CARE; PROPHYLAXIS; WEIGHT REDUCTION;

EID: 0035118615     PISSN: 11315768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Obesity
2. Obesity: Preventing and managing the global epidemic: Report of a WHO consultation on obesity
3. Grupo colaborativo Español para el estudio de obesidad. Prevalencia de obesidad en España; estudio SEEDO 97
4. Cardiovascular risk factors in children from the Belgian Luxembourg Province: The Belgian Luxembourg Child Study
5. Childhood obesity and adult cardiovascular mortality
6. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents
7. Obesity in Europe: Prevalence and consequences for the use of medical care
8. Inheritance of the amount and distribution of human body fat
9. Avances en la base genética de la obesidad
10. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy
11. Leptin is a metabolic signal to the reproductive system
12. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
13. Changes in energy expenditure resulting from altered body weight
14. Food, obesity and non-insulin-dependent diabetes: Are there molecular links?
15. Elevated tumor necrosis factor alfa in sera of obese patients: Fall with weight loss
16. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters
17. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
18. Leptin receptors expressed on pancreatic beta-cells
19. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome
20. Visceral obesity: A "civilization syndrome"
21. A comparison of measurements of lean body mass derived by bioelectrical impedance, skinfold thickness and total body potassium. A study in obese and non-obese normal subjects
22. School-based approaches for preventing and treating obesity
23. Beneficial effects of modest weight loss
24. Obesity
25. Carbohydrates and obesity
26. Obesity: Some heat but not enough light
27. Obesity as an independent risk factor of cardiovascular disease: A 26 year follow-up of participants in the Framingham Heart Study
28. Ten-year outcomes of behavioural, family-based treatment for childhood obesity
29. Behavioural treatment of childhood and adolescent obesity
30. Appetite suppressant drugs and the risk of primary pulmonary hypertension
31. Valvular heart disease associated with fenfluramine-phentermine
32. The use of selective serotonin reuptake inhibitors in eating disorders
33. Fluoxetine: A randomized clinical trial in the treatment of obesity
34. Long-term pharmacotherapy in the management of obesity. National Task Force on the prevention and treatment of obesity
35. Efficacy and tolerability of sibutramine in obese patients: A doseranging study
36. Long-term weight loss with sibutramine
37. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
38. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study
39. Pharmacological treatment of obesity: Present status
40. Principio de precaución y tratamiento con fármacos de las personas obesas
41. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
42. Acarbosa-an update of its pharmacology and therapeutic use in diabetes mellitus